logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christian Schem

mammazentrum am krankenhaus jerusalem
H指数:36
被引数:8,131

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ABC8 Consensus: Assessment by a German Group of Experts

ABC8共识：德国专家组评估

Breast Care
IF2.1
2026-02-010
PRE
Ditsch, Nina; Untch, Michael; Fasching, Peter A.; Briest, Susanne; Ettl, Johannes; Haidinger, Renate; Luftner, Diana; Maurer, Christian; Muller, Volkmar; Park-Simon, Tjoung-Won; Ruckhaberle, Eugen; Schem, Christian; Schumacher-Wulf, Eva; Harbeck, Nadia; Wuerstlein, Rachel
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)

内分泌反应评估在HR阳性HER2阴性早期乳腺癌中的应用：WSG ADAPTcycle试验（n=5292）中局部与中央Ki67测量的符合情况

ESMO Open
IF8.3
2025-08-140
OAAI
M. Hamann; M. Christgen; O. Gluz; U. Nitz; S. Kuemmel; M. Braun; M. Thill; R. Wuerstlein; P. Wimberger; A. Hartkopf; C. Schem; M. Zaiss; V. Bjelic-Radisic; M. Just; K. Veselinovic; M. Vincent; M. Graeser; K. Krauss; O. Hoffmann; K. Lüdtke-Heckenkamp; R.E. Kates; C. zu Eulenburg; K. Jóźwiak; S. Burmeister; M. Hauptmann; F. Baehner; P. Schmid; H.-H. Kreipe; N. Harbeck
Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials

HER2+早期乳腺癌降级新辅助治疗后生存预测：一项基于三项WSG试验的合并分析

Annals of Oncology
IF65.4
2025-08-050
PREAI
M. Graeser; O. Gluz; C. Zu Eulenburg; S. Kuemmel; R. von Schumann; M. Christgen; R. Wuerstlein; E. Pelz; H.H. Kreipe; P. Schmid; M. Thill; M. Braun; J. Potenberg; C. Schumacher; J. Tio; J. Schumacher; L. Wujak; A.D. Hartkopf; M. Just; C. Schem; K. Luedtke-Heckenkamp; F. Hilpert; A. Kentsch; R.E. Kates; U. Nitz; N. Harbeck
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification

妊娠对乳腺癌免疫学的影响：免疫生物标志物和TIL量化

NPJ BREAST CANCER
IF7.6
2025-05-140
OA
Galas, Kristin; Gleitsmann, Moritz; Rey, Julia; Solbach, Christine; Witzel, Isabell; Karn, Thomas; Schmatloch, Sabine; Schem, Christian; Schneeweis, Andreas; Sinn, Bruno; Fehm, Tanja; Denkert, Carsten; Fasching, Peter; Litmeyer, Anne-Sophie; Marme, Frederik; Jank, Paul; Mueller, Volkmar; Seiler, Sabine; Stickeler, Elmar; Ortmann, Olaf; van Mackelenbergh, Marion; Nekljudova, Valentina; Holtschmidt, Johannes; Loibl, Sibylle
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer
CELL REPORTS MEDICINE
IF10.6
2024-11-010
OAAI
Denkert, Carsten; Schneeweiss, Andreas; Rey, Julia; Karn, Thomas; Hattesohl, Akira; Weber, Karsten E.; Rachakonda, Sivaramakrishna; Braun, Michael; Huober, Jens; Jank, Paul; Sinn, Hans-Peter; Zahm, Dirk-Michael; Felder, Barbel; Hanusch, Claus; Teply-Szymanski, Julia; Marme, Frederik; Fehm, Tanja; Thomalla, Jorg; V. Sinn, Bruno; Stiewe, Thorsten; Marczyk, Michal; Blohmer, Jens-Uwe; van Mackelenbergh, Marion; Schem, Christian; Staib, Peter; Link, Theresa; Muller, Volkmar; Stickeler, Elmar; Stover, Daniel G.; Solbach, Christine; Metzger-Filho, Otto; Jackisch, Christian; Geyer Jr, Charles E.; Fasching, Peter A.; Pusztai, Lajos; Nekljudova, Valentina; Untch, Michael; Loibl, Sibylle
Clinical outcomes in patients (pts) with HR+/HER2-early breast cancer (EBC) by prior systemic treatment (tx): A subgroup analysis of the NATALEE trial

HR+/HER2-早期乳腺癌（EBC）患者根据既往全身治疗（tx）的临床结局：NATALEE试验的亚组分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
McAndrew, N. P.; Chia, S.; Puglisi, F.; Bardia, A.; Izarzugaza Peron, Y.; Schem, C.; Xu, B.; Le Du, F.; Sharma, P.; Afenjar, K.; Akdere, M.; Gonzalez, J. P. Zarate; Chattar, Y.; Fasching, P. A.
Association of RAD51 and efficacy outcomes in patients with HER2-negative breast cancer (BC) and homologous recombination deficiency (HRD): Post-hoc analysis of the GeparOla trial

RAD51与HER2阴性乳腺癌（BC）患者中同源重组缺陷（HRD）疗效结局的关联：GeparOla试验的事后分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Villacampa, G.; Filmann, N.; Fasching, P. A.; Balmana, J.; Karn, T.; Marme, F.; Klare, P.; Mueller, V.; Schem, C.; Fehm, T. N.; Stickeler, E.; Van Mackelenbergh, M.; Felder, B.; Nekljudova, V.; Llop-Guevara, A.; Denkert, C.; Loibl, S.; Serra, V.
CDH1 mutations predict resistance to neoadjuvant taxane therapy
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Knappskog, Stian; Helwa, Reham; Rachakonda, Sivaramakrishna; Gansmo, Liv B.; Denkert, Carsten; Yates, Lucy R.; Solbach, Christine; Untch, Michael; Sinn, Bruno V.; Litmeyer, Anne-Sophie; Ataseven, Beyhan; Huober, Jens; Wedge, David C.; Karn, Thomas; Nikolaienko, Oleksii; Marme, Frederik; Fasching, Peter A.; Eikesdal, Hans Petter; Stickeler, Elmar; Schem, Christian; Jank, Paul; van Mackelenbergh, Marion; Muller, Volkmar; Felder, Baerbel; Holtschmidt, Johannes; Campbell, Peter J.; Loibl, Sibylle; Lonning, Per
Individual patient data meta-analysis of clinical and translational biomarkers for prediction of pathological complete response (pCR) after de-escalated therapy in HER2+breast cancer in four trials of the West German Study Group
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Graeser, Monika; Gluz, Oleg; zu Eulenburg, Christine; Kuemmel, Sherko; von Schumann, Raquel; Christgen, Matthias; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans-Heinrich; Schmid, Peter; Thill, Marc; Braun, Michael; Potenberg, Jochem; Schumacher, Claudia; Tio, Joke; Hartkopf, Andreas; Just, Marianne; Schem, Christian; Ludtke-Heckenkamp, Kerstin; Grischke, Eva-Maria; Hilpert, Felix; Kentsch, Angela; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; zu Eulenburg, Christine; Jozwiak, Katarzyna; Burmeister, Sandy; Baehner, Rick; Schmid, Peter; Kreipe, Hans-Heinrich; Harbeck, Nadia
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter WSG-ADAPTcycle trial (n=5,290)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; Eulenburg, Christine Zu; Schmid, Peter; Baehner, Rick; Kreipe, Hans-Heinrich; Harbeck, Nadia
Comparison of an Atezolizumab monotherapy window followed by Atezolizumab and chemotherapy vs. Atezolizumab and chemotherapy alone in triple negative breast cancer (TNBC) - final analysis of the neoadjuvant neoMono trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Kolberg, Hans-Christian; Schumacher, Johannes; Erber, Ramona; Braun, Michael; Fasching, Peter A.; Grischke, Eva-Maria; Schem, Christian; Lux, Michael P.; Deryal, Mustafa; Hoffmann, Oliver; Heinrich, Bernhard; Kunz, Georg; Lubbe, Kristina; Krabisch, Petra; Hartmann, Arndt; Raeth, Philip; Kasimir-Bauer, Sabine; Kolberg-Liedtke, Cornelia
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients
CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2024-04-250
OAAI
Massa, Chiara; Karn, Thomas; Weber, Karsten; Schneeweiss, Andreas; Hanusch, Claus; Blohmer, Jens Uwe; Zahm, Dirk-Michael; Jackisch, Christian; van Mackelenbergh, Marion; Thomalla, Joerg; Marme, Frederik; Huober, Jens; Mueller, Volkmar; Schem, Christian; Mueller, Anja; Stickeler, Elmar; Biehl, Katharina; Fasching, Peter A.; Untch, Michael; Loibl, Sibylle; Denkert, Carsten; Seliger, Barbara
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR plus ), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
FRONTIERS IN ONCOLOGY
IF3.3
2023-10-264
OAAI
Cazzaniga, Marina Elena; Ciaccio, Antonio; Danesi, Romano; Duhoux, Francois P.; Girmenia, Corrado; Zaman, Kalhil; Lindman, Henrik; Luppi, Fabrizio; Mavroudis, Dimitrios; Paris, Ida; Olubukola, Ayodele; Samreen, Ahmed; Schem, Christian; Singer, Christian; Snegovoy, Anton
Comparison of a mono Atezolizumab window followed by Atezolizumab and chemotherapy with Atezolizumab and chemotherapy in triple negative breast cancer - an interim analysis of the adaptive randomized neoadjuvant trial NeoMono
CANCER RESEARCH
IF16.6
2023-03-014
PRE
Kolberg, Hans-Christian; Schumacher, Johannes; Erber, Ramona; Braun, Michael; Heinrich, Bernhard; Hoffmann, Oliver; Fasching, Peter A.; Kunz, Georg; Lux, Michael P.; Schem, Christian; Grischke, Eva-Maria; Deryal, Mustafa; Lubbe, Kristina; Hartmann, Arndt; Kasimir-Bauer, Sabine; Kolberg-Liedtke, Cornelia
Immunohistochemical markers and determinants of clinical response in the Penelope-B trial
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Knudsen, Erik S.; Rachakonda, Sivaramakrishna; Marme, Frederik; Martin, Miguel; Untch, Michael; Bonnefoi, Herve R.; Schmitt, Wolfgang D.; Kim, Sung-Bae; Bear, Harry D.; Witkiewicz, Agnieszka; Im, Seock-Ah; DeMichele, Angela; Van't Veer, Laura; McCarthy, Nicole; Sinn, Bruno V.; Gelmon, Karen; Garcia-Saenz, Jose Angel; Kelly, Catherine M.; Reimer, Toralf; Turner, Nicholas; Rojo, Federico; Filipits, Martin; Fasching, Peter A.; Schem, Christian; Martin, Lesley-Ann; Liu, Yuan; Toi, Masakazu; Rugo, Hope; Gnant, Michael; Makris, Andreas; Furlanetto, Jenny; Weber, Karsten; Denkert, Carsten; Loibl, Sibylle
Immunological and clinical consequences of durvalumab treatment in combination to neoadjuvant chemotherapy in triple-negative breast cancer patients

durvalumab联合新辅助化疗治疗三阴性乳腺癌患者的免疫学和临床后果

CANCER RESEARCH
IF16.6
2023-03-012
PRE
Massa, Chiara; Karn, Thomas; Weber, Karsten; Schneeweiss, Andreas; Hanusch, Claus; Blohmer, Jens-Uwe; Zahm, Dirk-Michael; Jackisch, Christian; van Mackelenbergh, Marion; Thomalla, Jorg; Marme, Frederik; Huober, Jens; Mueller, Volkmar; Schem, Christian; Mueller, Anja; Stickeler, Elmar; Biehl, Katharina; Fasching, Peter A.; Untch, Michael; Loibl, Sibylle; Denkert, Carsten; Seliger, Barbara
Outcome analysis of HER2-zero or HER2-low hormone receptor-positive (HR plus ) breast cancer patients - characterization of the molecular phenotype in combination with molecular subtyping
CANCER RESEARCH
IF16.6
2023-03-012
PRE
Denkert, Carsten; Martin, Miguel; Untch, Michael; Bonnefoi, Herve R.; Knudsen, Erik S.; Im, Seock-Ah; DeMichele, Angela; Witkiewicz, Agnieszka; Van't Veer, Laura; Kim, Sung-Bae; Bear, Harry D.; McCarthy, Nicole; Gelmon, Karen; Marme, Frederik; Garcia-Saenz, Jose Angel; Turner, Nicholas; Rojo, Federico; Filipits, Martin; Martin, Lesley-Ann; Fasching, Peter A.; Schem, Christian; Kelly, Catherine M.; Reimer, Toralf; Toi, Masakazu; Rugo, Hope; Gnant, Michael; Makris, Andreas; Liu, Yuan; Weber, Karsten; Rachakonda, Sivaramakrishna; Loibl, Sibylle
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

EVI1在早期乳腺癌新辅助化疗患者中的表达

BMC CANCER
IF3.4
2022-10-050
OAAI
Leichsenring, Jonas; Vladimirova, Valentina; Solbach, Christine; Karn, Thomas; Ataseven, Beyhan; Sinn, Bruno Valentin; Barinoff, Jana; Mueller, Volkmar; Blohmer, Jens-Uwe; Schem, Christian; Engels, Knut; Marme, Frederik; Fisseler-Eckhoff, Annette; Fasching, Peter A.; Stickeler, Elmar; van Mackelenbergh, Marion; Denkert, Carsten; Stenzinger, Albrecht; Loibl, Sibylle; Groeschel, Stefan

研究方向

暂未获取到该数据
P
Peter A. Fasching
H 指数:121论文数:2,055被引数:7.8万
C
Carsten Denkert
H 指数:116论文数:1,285被引数:6.9万
S
Sibylle Loibl
H 指数:131论文数:1,517被引数:9.5万
T
Thomas Karn
H 指数:46论文数:492被引数:1.0万
M
Michael Untch
H 指数:108论文数:1,416被引数:7.2万
E
Elmar Stickeler
H 指数:54论文数:683被引数:1.1万
F
Frederik Marmé
H 指数:68论文数:786被引数:2.1万
M
Marion van Mackelenbergh
H 指数:25论文数:256被引数:4,109
A
Andreas Schneeweiß
H 指数:98论文数:1,658被引数:5.2万
K
Karsten E. Weber
H 指数:30论文数:193被引数:7,470